rifampicinisoniazidisoniazidCImoxifloxacinlevofloxacinbedaquiline
…s introduced, initially referring to TB resistant to isoniazid, rifampicin, and at least three of the six main classes of second line drug…
15articles mentioning drugs
34drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: rosuvastatin ×
rosuvastatin
This drug is selected. Its supporting articles are shown below.
Articles mentioning rosuvastatin
15 articles · page 1 of 299.4%
RosuvastatinaspirinRosuASAelastase-induced aneurysmsthromboembolic complications
…omography), and histological/MPM strut coverage were evaluated. Rosuvastatin serum concentration was correlated with endothelial cell covera…
rosuvastatinatorvastatinPWHdiabetes mellitusDMHIV
…essment for insulin resistance (HOMA-IR) among PWH treated with rosuvastatin vs. atorvastatin. The secondary objectives were to evaluate bas…
rosuvastatinatorvastatinstatinscardiovascular riskNational Volume-Based Procurement (NVBP) policy
…n and expenditure in statin was contributed by atorvastatin and rosuvastatin. After the NVBP policy, the utilisation of atorvastatin and ros…
ezetimiberosuvastatinhigh-intensity statinmoderate-intensity statinacute myocardial infarctionAMINCT04499859Institutional Review Board of Seoul St. Mary’s HospitalHigh-intensity statin therapy
…randomised 1:1 to receive either moderate-intensity statin with ezetimibe (rosuvastatin 5 mg with ezetimibe 10 mg) or high-intensity stat…
AtorvastatinEzetimibeRosuvastatinbempedoic acidPravastatinSimvastatinFibrateCKDHypertensioncardiovascular events
…arget (111) Off target (197) Both groups (308) Statin% 95 85 89 Atorvastatin Total Number% 62 61 62 Mean Dose (mg) 57.71 (SD 25.03) 58.33 (S…
bempedoic acidrosuvastatinatorvastatinatherosclerotic cardiovascular diseasefamilial hypercholesterolaemiaMedical Ethical Research Committee in The NetherlandsNISONELipid-lowering therapies
…rotein Convertase Subtilisin/Kexin type 9 (PCSK9) inhibitors or bempedoic acid. Recent studies suggest that N=1-interventions may help disting…
rosuvastatinASCVDischaemic heart diseaseAtherosclerotic cardiovascular diseaseEstonian Committee on Bioethics and Human ResearchEstonian Ethics Committee for Medicinal Products
…allocation ratio to intervention (n=1350), receiving preventive rosuvastatin 20 mg treatment or control (n=1350), receiving current standard…
89.8%
inclisiranevolocumabalirocumabatorvastatinrosuvastatinperipheral arterial diseaseischaemic heart diseaseischaemic cerebrovascular diseaseheterozygous familial hypercholesterolaemiaHeFH+2 more
…itors (PCSK9 inhibitors), including evolocumab, alirocumab, and inclisiran, are potent lipid-lowering agents indicated for patients at hig…
evolocumabezetimibeevolucumabalirocumabrosuvastatinatorvastatinsecondary cardiovascular events or strokes
…ilisin/kexin type 9 inhibitors (PCSK9i), such as alirocumab and evolocumab, effectively manage cLDL levels. However, the relative efficacy…
rosuvastatinmanidipinehypertensiondyslipidaemiadiabetesstroke
…, hypertension and dyslipidaemia. She was taking manidipine and rosuvastatin. On presentation, she was alert and oriented. Vital signs inclu…
atorvastatinlovastatinpravastatinfluvastatinPitavastatinsimvastatinrosuvastatinrhabdomyolysisliver
…006, random effects model), covering various statins, including atorvastatin, simvastatin, rosuvastatin, fluvastatin, pitavastatin, pravasta…